JACC-CardioOncology
JACC: CardioOncology is an online open access journal published by Elsevier on behalf of the American College of Cardiology Foundation, launched in September 2019 as a specialist title in the JACC family, devoted to the cardiovascular care of patients with cancer, with a 2025 Journal Impact Factor of 15.5(JACC: CardioOncology)是由(Elsevier)代表(American College of Cardiology Foundation)出版的在线开放获取期刊,2019 年 9 月创刊,属(JACC)系列专科刊,致力于癌症患者的心血管照护,2025 年影响因子为 15.5。
Scope
- It serves to advance the cardiovascular care of cancer patients through rigorously executed, innovative science and evidence-based knowledge通过严谨创新的科学与循证知识,推进癌症患者的心血管照护。
- It seeks to transform the field of cardio-oncology and to engage and educate the cardiovascular and oncology communities旨在变革心脏肿瘤学领域,并联络与教育心血管与肿瘤学界。
- It publishes pre-clinical, translational and clinical research as well as best practices in cardio-oncology刊载临床前、转化与临床研究以及心脏肿瘤学最佳实践。[1]
- Broad areas of interest include disease mechanisms, model systems and novel and conventional therapeutics广泛关注的领域包括疾病机制、模型系统以及新式与传统治疗。
- It covers epidemiology, precision medicine and primary and secondary prevention涵盖流行病学、精准医学以及一级与二级预防。
- Disease states of interest include amyloidosis, cardiovascular risk factors, heart failure and vascular disease关注的疾病状态包括淀粉样变性、心血管危险因素、心力衰竭与血管疾病。
History
- It was launched in September 2019, when its first issue appeared该刊于 2019 年 9 月推出首期。
- It is an official journal of the American College of Cardiology是(American College of Cardiology)的官方期刊。
- It is published by Elsevier Inc. on behalf of the American College of Cardiology Foundation由(Elsevier)代表(American College of Cardiology Foundation)出版。
- It is an online-only journal and is fully open access为纯在线期刊,且完全开放获取。
- It publishes six issues per year每年出版六期。
- Its Journal Impact Factor rose from 6.25 in 2021 to 15.5 in 2025其影响因子从 2021 年的 6.25 升至 2025 年的 15.5。
Editors
- The Editor-in-Chief is Bonnie Ky of the Perelman School of Medicine at the University of Pennsylvania主编为(Perelman School of Medicine at the University of Pennsylvania)的(Bonnie Ky)。
- The Deputy Editors are Saro H. Armenian of City of Hope and Ronald Witteles of Stanford University Medical Center副主编为(City of Hope)的(Saro H. Armenian)与(Stanford University Medical Center)的(Ronald Witteles)。
- Associate Editors include Carmen Bergom of Washington University School of Medicine and Darryl P. Leong of McMaster University副编辑包括(Washington University School of Medicine)的(Carmen Bergom)与(McMaster University)的(Darryl P. Leong)。
- Further Associate Editors are Pilar Martin of the Spanish National Center for Cardiovascular Research and Vivek Narayan of the University of Pennsylvania其他副编辑为(Spanish National Center for Cardiovascular Research)的(Pilar Martin)与(University of Pennsylvania)的(Vivek Narayan)。
- Other Associate Editors include Alexandra Thomas of Duke Cancer Institute and Jenica Nicholls Upshaw of Beth Israel Deaconess Medical Center其他副编辑还包括(Duke Cancer Institute)的(Alexandra Thomas)与(Beth Israel Deaconess Medical Center)的(Jenica Nicholls Upshaw)。
- Senior Advisors include Eugene Braunwald of Brigham and Women's Hospital and Joseph R. Carver of the University of Pennsylvania高级顾问包括(Brigham and Women's Hospital)的(Eugene Braunwald)与(University of Pennsylvania)的(Joseph R. Carver)。
References
- ^Sara Tyebally, Daniel Chen, Sanjeev Bhattacharyya, et al. Cardiac Tumors. JACC: CardioOncology, 2020, 2(2): 293-311. doi:10.1016/j.jaccao.2020.05.009